<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="case-report"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int J Chron Obstruct Pulmon Dis</journal-id><journal-id journal-id-type="publisher-id">copd</journal-id><journal-title-group><journal-title>International Journal of Chronic Obstructive Pulmonary Disease</journal-title></journal-title-group><issn pub-type="ppub">1176-9106</issn><issn pub-type="epub">1178-2005</issn><publisher><publisher-name>Dove</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11786593</article-id><article-id pub-id-type="publisher-id">496167</article-id><article-id pub-id-type="doi">10.2147/COPD.S496167</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Trial Report</subject></subj-group></article-categories><title-group><article-title>Post-Acute Care Interventions in Patients Hospitalized Due to COPD Exacerbation Before and After Implementation of an Integrated Care Program</article-title><alt-title alt-title-type="running-authors">H&#x000fc;bsch et al</alt-title><alt-title alt-title-type="running-title">H&#x000fc;bsch et al</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2339-1847</contrib-id><name><surname>H&#x000fc;bsch</surname><given-names>Christine</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2158-2321</contrib-id><name><surname>Clarenbach</surname><given-names>Christian F</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Franzen</surname><given-names>Daniel P</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2610-636X</contrib-id><name><surname>Schmid-Mohler</surname><given-names>Gabriela</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><aff id="aff0001"><label>1</label><institution>Centre of Clinical Nursing Science, University Hospital Zurich</institution>, <addr-line>Zurich</addr-line>, <country>Switzerland</country></aff><aff id="aff0002"><label>2</label><institution>Division of Pulmonology, University Hospital Zurich</institution>, <addr-line>Zurich</addr-line>, <country>Switzerland</country></aff><aff id="aff0003"><label>3</label><institution>Faculty of Medicine, University of Zurich</institution>, <addr-line>Zurich</addr-line>, <country>Switzerland</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Gabriela Schmid-Mohler, Email gabriela.schmid@usz.ch</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>20</volume><fpage>207</fpage><lpage>216</lpage><history><date date-type="received"><day>16</day><month>9</month><year>2024</year></date><date date-type="accepted"><day>16</day><month>9</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; 2025 H&#x000fc;bsch et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>H&#x000fc;bsch et al.</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is published by Dove Medical Press Limited, and licensed under a Creative Commons Attribution License. The full terms of the License are available at <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec><title>Purpose</title><p>In Switzerland, while the quality of acute inpatient care for patients with AECOPD is high, a lack of post-acute care interventions has been identified. To correct this shortfall, an integrated care program for patients with AECOPD was initiated at University Hospital Zurich. The study&#x02019;s aim was to compare defined post-acute care intervention implementation rates before and after the new program&#x02019;s implementation.</p></sec><sec><title>Methods</title><p>A retrospective medical chart review was performed regarding patients hospitalized due to AECOPD between July 2019 and March 2023. The control group (CG) had received usual care, while the intervention group (IG) received the newly implemented program. Implementation rates were compared with Pearson&#x02019;s chi-squared-test or Fisher&#x02019;s exact test.</p></sec><sec><title>Results</title><p>Charts of 107 participants (IG: 55, CG: 52) were evaluated. Implementation rates increased significantly in the IG for exacerbation management, dyspnea management, recommendation for rehabilitation, smoking cessation advice, evaluation of inhalation technique and recommendation of vaccination (p &#x0003c; 0.05) but not for physical activity, post-discharge medical follow-up or nutrition.</p></sec><sec><title>Conclusion</title><p>This study provides promising evidence that the introduction of a hospital-initiated integrated care program can significantly increase the implementation rate of post-acute care interventions in patients hospitalized due to AECOPD.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>COPD</kwd><kwd>exacerbation</kwd><kwd>implementation</kwd><kwd>post-acute care</kwd><kwd>nursing</kwd></kwd-group><funding-group><award-group><funding-source>
<institution-wrap><institution>research grant from LUNGE ZUERICH, Switzerland</institution></institution-wrap>
</funding-source></award-group><funding-statement>This work was supported by a research grant from LUNGE ZUERICH, Switzerland.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="3"/><ref-count count="37"/><page-count count="10"/></counts></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>In Switzerland, approximately 400&#x02019;000 persons live with COPD.<xref rid="cit0001" ref-type="bibr">1</xref> This condition&#x02019;s most common complication is acute exacerbation of COPD (AECOPD), which is associated with disease progression and increased hospitalizations, leading to higher illness-related costs and excess mortality.<xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0003" ref-type="bibr">3</xref> Beneficial health behaviors, eg, early exacerbation recognition, symptom management, smoking cessation, regular physical activity, healthy diet, medication adherence, pneumococcal and influenza vaccination and dyspnea management, are known to reduce exacerbation and hospitalization rates.<xref rid="cit0003" ref-type="bibr">3&#x02013;5</xref> Structured and personalized self-management interventions addressing these behaviors are recommended for integration into standard inpatient and post-acute care.<xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0006" ref-type="bibr">6&#x02013;9</xref> However, interventions that influence health behaviors are inadequately implemented in the hospital setting.<xref rid="cit0010" ref-type="bibr">10</xref>,<xref rid="cit0011" ref-type="bibr">11</xref> Also, while the quality of acute inpatient care for patients with AECOPD is high in Switzerland, underuse of post-acute care interventions and coordinated self-management support across settings has been identified.<xref rid="cit0012" ref-type="bibr">12</xref>,<xref rid="cit0013" ref-type="bibr">13</xref> In 2012 and 2013, only 1.9% of 263&#x000a0;hospitalized patients in three public hospitals in the Canton of Zurich received patient education and self-management support while hospitalized due to AECOPD.<xref rid="cit0012" ref-type="bibr">12</xref> Barriers to the implementation of such interventions include the prioritization of acute care interventions, limited human resources, missing expertise in chronic care and behavior change and the lack of financial reimbursement.<xref rid="cit0013" ref-type="bibr">13</xref>,<xref rid="cit0014" ref-type="bibr">14</xref> Moreover, the proportion of referrals for pulmonary rehabilitation in Switzerland is below 50%,<xref rid="cit0015" ref-type="bibr">15</xref> despite evidence indicating that the timely initiation of pulmonary rehabilitation is beneficial in patients with AECOPD.<xref rid="cit0016" ref-type="bibr">16</xref></p><p>At University Hospital Zurich, an integrated care program coordinated by a newly implemented advanced nursing practice (ANP) team was chosen to close this gap: the Nurse-led Integrated Care COPD (NICCO) program.<xref rid="cit0013" ref-type="bibr">13</xref> This structured, patient-tailored behavioral program is initiated during hospitalization and continues for 13&#x000a0;weeks, mainly by telephone. The implementation of the NICCO program started in June 2020.<xref rid="cit0017" ref-type="bibr">17</xref> To investigate the newly implemented program&#x02019;s feasibility and effect, the NICCO pilot study was conducted using a monocentric parallel cluster design with a baseline period.<xref rid="cit0018" ref-type="bibr">18</xref></p><p>The current sub-study of the NICCO study was founded on the assumption that adoption of the new integrated care program would increase the implementation rate of post-acute care interventions in patients hospitalized due to AECOPD. Therefore, its aim was to compare the implementation rates of defined post-acute care interventions before and after the integrated care program&#x02019;s implementation.</p></sec><sec id="s0002"><title>Materials and Methods</title><sec id="s0002-s2001"><title>The NICCO Program</title><p>The NICCO program&#x02019;s development followed a Behavior Change Wheel (BCW)-based methodological approach to formulate and evaluate interventions concerning eight key elements of COPD management: 1. exacerbation and dyspnea management (using action plans); 2. physical activity; 3. referral to rehabilitation; 4. smoking cessation; 5. adherence to nutrition to prevent or manage underweight; 6. adherence to inhalation; 7. adherence to vaccination recommendations; and 8. post-discharge follow-up. The program also focuses on illness-related emotional distress and advanced end-of-life care planning.</p><p>While the ANP team&#x02014;a team of nurses with doctoral, master&#x02019;s, and bachelor&#x02019;s degrees and/or experience in the field of pulmonology&#x02014;leads the overall NICCO project, numerous other professionals (nurses, physicians, physiotherapists and, if needed, social workers, nutritionists and psychiatrists) also play important roles in the program. Beginning during patients&#x02019; inpatient stay for AECOPD, the program is delivered via face-to-face contact and lasts 13-weeks. During each patient&#x02019;s stay, the ANP team, the responsible physician, a physiotherapist and the ward nurses deliver the various intervention packages that constitute the integrated care program (<xref rid="t0001" ref-type="table">Table 1</xref>). For outpatient follow-up, ANP team members contact the patient&#x02014;mainly by telephone&#x02014;every one or two weeks for at least twelve weeks. Each contact includes a re-assessment of the patient&#x02019;s target behaviors and individual progress within the program. A detailed description of the intervention is available elsewhere.<xref rid="cit0017" ref-type="bibr">17</xref>
<table-wrap position="float" id="t0001"><label>Table 1</label><caption><p>Overview of Post-Acute Care Interventions During Hospital Stay: Usual Care versus the Nurse-Led Integrated Care COPD (NICCO) Program</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Post-Acute care Intervention and Evidence</th><th align="center" colspan="2" rowspan="1">Usual Care</th><th align="center" colspan="2" rowspan="1">NICCO Program</th></tr><tr><th rowspan="1" colspan="1">Content</th><th rowspan="1" colspan="1">Responsible Profession</th><th rowspan="1" colspan="1">Content</th><th rowspan="1" colspan="1">Responsible Profession</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">Exacerbation Management:Self-management interventions with exacerbation action plan improve health-related quality of life and reduce readmission risk<xref rid="cit0003" ref-type="bibr">3</xref>,<xref rid="cit0008" ref-type="bibr">8</xref>,<xref rid="cit0019" ref-type="bibr">19&#x02013;21</xref></td><td rowspan="2" colspan="1">No standardized procedure</td><td rowspan="2" colspan="1">Physician</td><td rowspan="1" colspan="1">Assessment and intervention regarding symptom management. Decision, recommendation and instruction of action plan</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="1" colspan="1">Prescription and explanation of the medications in the action plan</td><td rowspan="1" colspan="1">Physician</td></tr><tr><td rowspan="1" colspan="1">Dyspnea Management:Relieving dyspnea limits disability, reduces distress, improves quality of life and reduces doctor visits<xref rid="cit0003" ref-type="bibr">3</xref></td><td rowspan="1" colspan="1">Situation-specific assessment and intervention regarding dyspnea management</td><td rowspan="1" colspan="1">Ward Nurse</td><td rowspan="1" colspan="1">Reduce anxiety and dyspnea<break/>General assessment and intervention regarding dyspnea management</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="2" colspan="1">Physical Activity:Low physical activity is associated with higher mortality, increased risk for exacerbations and hospitalisations<xref rid="cit0025" ref-type="bibr">25</xref>,<xref rid="cit0026" ref-type="bibr">26</xref></td><td rowspan="1" colspan="1">Prescription of physiotherapy in selected patients</td><td rowspan="1" colspan="1">Physician</td><td rowspan="1" colspan="1">Exercising 30&#x000a0;minutes per day and supervised exercise<break/>Information about the importance of exercise. Prescription of physiotherapy in all patients</td><td rowspan="1" colspan="1">Physician</td></tr><tr><td rowspan="1" colspan="1">Assessment and intervention if there is a prescription</td><td rowspan="1" colspan="1">Physiotherapist</td><td rowspan="1" colspan="1">Assessment and intervention in all patients. Preparation of a movement plan</td><td rowspan="1" colspan="1">Physiotherapist</td></tr><tr><td rowspan="3" colspan="1">Rehabilitation:Pulmonary rehabilitation leads to lower mortality and fewer readmissions<xref rid="cit0016" ref-type="bibr">16</xref>,<xref rid="cit0027" ref-type="bibr">27</xref></td><td rowspan="3" colspan="1">Discussion and prescription if required</td><td rowspan="3" colspan="1">Physician</td><td rowspan="1" colspan="1">Discussion and prescription if required</td><td rowspan="1" colspan="1">Physician</td></tr><tr><td rowspan="2" colspan="1">Discuss expectations and goals regarding rehabilitation with the patient. Make a recommendation.</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="1" colspan="1">Physiotherapist</td></tr><tr><td rowspan="4" colspan="1">Smoking Cessation:Quitting smoking and staying smoke-free are known to have the greatest capacity to influence prognosis and progression of COPD<xref rid="cit0003" ref-type="bibr">3</xref></td><td rowspan="1" colspan="1">Information about the importance of smoking cessation. Prescription of nicotine replacement products</td><td rowspan="1" colspan="1">Physician</td><td rowspan="1" colspan="1">Assessment and Intervention. Referral to smoking cessation counseling if desired</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="3" colspan="1">Offer and administer nicotine replacement products</td><td rowspan="3" colspan="1">Ward Nurse</td><td rowspan="1" colspan="1">Information about the importance of smoking cessation. Prescription of nicotine replacement products</td><td rowspan="1" colspan="1">Physician</td></tr><tr><td rowspan="1" colspan="1">Offer and administer nicotine replacement products</td><td rowspan="1" colspan="1">Ward Nurse</td></tr><tr><td rowspan="1" colspan="1">Making an appointment for outpatient smoking counseling</td><td rowspan="1" colspan="1">Smoking Cessation Counseling</td></tr><tr><td rowspan="2" colspan="1">Nutrition:Low body weight and malnutrition are common in patients with COPD and are related to disease progression<xref rid="cit0003" ref-type="bibr">3</xref></td><td rowspan="2" colspan="1">Prescription of nutritional counseling for selected patients</td><td rowspan="2" colspan="1">Physician</td><td rowspan="1" colspan="1">Screening (NRS; BMI), Intervention if NRS&#x02265;4</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="1" colspan="1">Intervention if NRS&#x02265;4</td><td rowspan="1" colspan="1">Nutritionist</td></tr><tr><td rowspan="2" colspan="1">Inhalation Adherence:Prevalence of inhalation non-adherence is high (22&#x02013;93%)<xref rid="cit0028" ref-type="bibr">28</xref>; and up to 90% of patients inhale incorrectly <xref rid="cit0029" ref-type="bibr">29</xref>,<xref rid="cit0030" ref-type="bibr">30</xref></td><td rowspan="2" colspan="1">Assessment and Intervention regarding adherence and technique</td><td rowspan="2" colspan="1">Ward Nurse</td><td rowspan="1" colspan="1">Assessment and Intervention regarding adherence and technique</td><td rowspan="1" colspan="1">Ward Nurse</td></tr><tr><td rowspan="1" colspan="1">Assess adherence (ZATA)</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="2" colspan="1">Influenza and Pneumococcal Vaccination:Influenza and pneumococcal vaccination decrease the incidence of lower respiratory tract infection<xref rid="cit0003" ref-type="bibr">3</xref></td><td rowspan="2" colspan="1">Check vaccination status and make recommendation if necessary</td><td rowspan="2" colspan="1">Physician</td><td rowspan="2" colspan="1">Check vaccination status and make recommendation if necessary</td><td rowspan="1" colspan="1">ANP Team</td></tr><tr><td rowspan="1" colspan="1">Physician</td></tr><tr><td rowspan="2" colspan="1">Post-discharge medical Follow-up:Early medical follow-ups of less than four weeks are associated with fewer exacerbation-related readmissions<xref rid="cit0003" ref-type="bibr">3</xref></td><td rowspan="2" colspan="1">Write exit report and organize post-discharge medical follow-up</td><td rowspan="2" colspan="1">Physician</td><td rowspan="1" colspan="1">Write exit report and organize post-discharge medical follow-up</td><td rowspan="1" colspan="1">Physician</td></tr><tr><td rowspan="1" colspan="1">Report and Email family doctor information about integrated care program and initiated self-management interventions</td><td rowspan="1" colspan="1">ANP Team</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><bold>Abbreviations</bold>: BMI, body mass index; NRS, nutrition risk screening.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0002-s2002"><title>Data Collection</title><p>We performed a retrospective medical chart review of patients hospitalized at University Hospital Zurich, Switzerland, between 1 July 2019 and 31 March 2023 due to AECOPD. In this tertiary academic referral center, patients with AECOPD usually stay either in the Division of Internal Medicine or in the Division of Pulmonology. For baseline data, charts were reviewed from July 2019 to June 2020 (control group). For data recorded after implementation of the NICCO program, charts were reviewed from June 2020 to March 2023 (intervention group). The control group received usual care, while the intervention group received the newly implemented NICCO program (<xref rid="t0001" ref-type="table">Table 1</xref>). Inclusion criteria were a confirmed diagnosis of COPD, hospitalization due to a COPD exacerbation treated with steroids and/or antibiotics,<xref rid="cit0031" ref-type="bibr">31</xref> age 18 or older and hospitalization on an Internal Medicine or Pulmonology ward. Exclusion criteria were cognitive impairment and not speaking any of our eleven supported languages, ie, German, French, Italian, English, Spanish, Portuguese, Serbian, Tamil, Hindi, Turkish or Slovakian. In cases of subsequent hospitalization due to AECOPD, only the first episode treated during the study period was considered. The study team identified prospective participants via regular screening of all in-patients&#x02019; electronic medical records. Eligible patients were contacted by the study team and provided with a participant information package. Patients were included either if they gave informed consent to participate in the NICCO study, ie, they allowed the collection of data from their electronic patient records, or if they gave general consent for data extraction from their records.</p><p>Data were collected using an anonymized case report form based on that used by Markun et al.<xref rid="cit0012" ref-type="bibr">12</xref> Our form included sociodemographic characteristics, disease-specific data and variables regarding post-acute care interventions. Assessed post-acute care interventions were as follows: 1. exacerbation management (assessment, drafting and instruction of an action plan); 2. dyspnea management (interventions regarding dyspnea and/or anxiety); 3. interventions regarding physical activity; 4. recommendations for referral to rehabilitation; 5. smoking cessation advice (to current smokers); 6. nutrition counselling; 7. evaluation of inhalation technique; 8. assessment and recommendation of influenza and/or pneumococcal vaccination; and 9. post-discharge medical follow-up recommendations by physician.</p><p>Entries made to electronic patient records during their AECOPD hospitalization were searched for the specific interventions allocated to them, including reports from physicians, nurses, physiotherapists, nutritionists, and social services. We checked whether post-acute care interventions had been carried out (documented) during their hospitalization. Neither the interventions&#x02019; quality nor their results were evaluated. Data were entered by two master&#x02019;s program nurses and double-checked by a study nurse. The first author randomly tested the data, making any necessary decisions in cases of ambiguity or disagreement between the raters&#x02019; assessments.</p></sec><sec id="s0002-s2003"><title>Data Analysis</title><p>Descriptive statistics were calculated, ie, counts, percentages, medians and interquartile ranges (the ranges of values between each dataset&#x02019;s 75th and 25th percentiles). To check for a difference between group allocation (control vs intervention group) regarding implementation rates, the Pearson&#x02019;s chi-square test (X<sup>2</sup>) was performed. If the expected cell frequencies were &#x02264;5, Fisher&#x02019;s exact test was used. Statistical analyses used the SPSS Statistics, version 29 software package.<xref rid="cit0032" ref-type="bibr">32</xref> For the sociodemographic characteristics and disease-specific data, missing data were excluded from the median and interquartile range calculations. For the interventions, missing data (no documentation found) were counted as not performed.</p></sec><sec id="s0002-s2004"><title>Ethical Considerations</title><p>This study was part of the &#x0201c;Nurse-led integrated care to improve quality of life in COPD patients with a pulmonary exacerbation (NICCO)&#x0201d; study (<underline><ext-link xlink:href="http://www.kofam.ch" ext-link-type="uri">www.kofam.ch</ext-link></underline>, SNCTP000003402) and approved by the governmental ethics committee (BASEC No. 2019&#x02013;00797). The study followed the principles of the Declaration of Helsinki.<xref rid="cit0033" ref-type="bibr">33</xref> After participants were informed in writing and orally about the study, and understood that participation was voluntary, all signed written consent for the retrieval of their data from their electronic patient records. Data anonymization and confidentiality were ensured.</p></sec></sec><sec id="s0003"><title>Results</title><sec id="s0003-s2001"><title>Participants</title><p>Data from both the control (n = 52) and the intervention group (n = 55) were included in the electronic chart review. The overall median length of stay was 8 days (IQR: 6&#x02013;10; control group median: 7 days (IQR: 6&#x02013;10); intervention group median: 8 days (IQR: 6&#x02013;11)). For participants&#x02019; sociodemographic characteristics and disease-specific data, see <xref rid="t0002" ref-type="table">Table 2</xref>.
<table-wrap position="float" id="t0002"><label>Table 2</label><caption><p>Sociodemographic Characteristics and Disease-Specific Participant Data</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Variable</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Control Group (n=52) n or Median (% or IQR)</th><th rowspan="1" colspan="1">Intervention Group (n=55) n or Median (% or IQR)</th><th rowspan="1" colspan="1">Overall (n=107) n or Median (% or IQR)</th></tr></thead><tbody><tr><td rowspan="4" colspan="1">Sociodemographic Characteristics</td><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">68.5 (62&#x02013;76)</td><td rowspan="1" colspan="1">69 (63&#x02013;75)</td><td rowspan="1" colspan="1">69 (62&#x02013;75)</td></tr><tr><td rowspan="1" colspan="1">Gender (male)</td><td rowspan="1" colspan="1">29 (55.8%)</td><td rowspan="1" colspan="1">29 (52.7%)</td><td rowspan="1" colspan="1">58 (54.2%)</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td rowspan="1" colspan="1">23.7 (21&#x02013;28)</td><td rowspan="1" colspan="1">22.8 (19&#x02013;28)</td><td rowspan="1" colspan="1">23.3 (20&#x02013;28)</td></tr><tr><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1">1 (0.9%)</td></tr><tr><td rowspan="4" colspan="1">Social Situation and Support</td><td rowspan="1" colspan="1">Living alone</td><td rowspan="1" colspan="1">27 (51.9%)</td><td rowspan="1" colspan="1">24 (43.5%)</td><td rowspan="1" colspan="1">51 (47.7%)</td></tr><tr><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">4 (7.7%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">4 (3.7%)</td></tr><tr><td rowspan="1" colspan="1">Paid support and/ or support from social environment</td><td rowspan="1" colspan="1">27 (51.9%)</td><td rowspan="1" colspan="1">35 (63.6%)</td><td rowspan="1" colspan="1">62 (58%)</td></tr><tr><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">6 (11.5%)</td><td rowspan="1" colspan="1">1 (1.8%)</td><td rowspan="1" colspan="1">7 (6.5%)</td></tr><tr><td rowspan="5" colspan="1">GOLD Stage</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">1 (1.9%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">1 (0.9%)</td></tr><tr><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">13 (25%)</td><td rowspan="1" colspan="1">9 (16.4%)</td><td rowspan="1" colspan="1">22 (20.6%)</td></tr><tr><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">18 (34.6%)</td><td rowspan="1" colspan="1">20 (36.4%)</td><td rowspan="1" colspan="1">38 (35.5%)</td></tr><tr><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">14 (26.9%)</td><td rowspan="1" colspan="1">23 (41.8%)</td><td rowspan="1" colspan="1">37 (34.6%)</td></tr><tr><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">6 (11.6%)</td><td rowspan="1" colspan="1">3 (5.4%)</td><td rowspan="1" colspan="1">9 (8.3%)</td></tr><tr><td rowspan="5" colspan="1">Smoking Status</td><td rowspan="1" colspan="1">Pack years</td><td rowspan="1" colspan="1">50 (35&#x02013;82)</td><td rowspan="1" colspan="1">50 (39&#x02013;81)</td><td rowspan="1" colspan="1">50 (39&#x02013;81)</td></tr><tr><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">5</td></tr><tr><td rowspan="1" colspan="1">Never smoker</td><td rowspan="1" colspan="1">2 (3.8%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">2 (1.9%)</td></tr><tr><td rowspan="1" colspan="1">Ex-smoker</td><td rowspan="1" colspan="1">36 (69.2%)</td><td rowspan="1" colspan="1">38 (69.1%)</td><td rowspan="1" colspan="1">74 (69.2%)</td></tr><tr><td rowspan="1" colspan="1">Current smoker</td><td rowspan="1" colspan="1">14 (26.9%)</td><td rowspan="1" colspan="1">17 (30.9%)</td><td rowspan="1" colspan="1">31 (29%)</td></tr><tr><td rowspan="1" colspan="1">Oxygen Therapy</td><td rowspan="1" colspan="1">Having long-term oxygen prescription</td><td rowspan="1" colspan="1">24 (46.2%)</td><td rowspan="1" colspan="1">25 (45.5%)</td><td rowspan="1" colspan="1">49 (45.8%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">15 (28.8%)</td><td rowspan="1" colspan="1">7 (12.7%)</td><td rowspan="1" colspan="1">22 (20.6%)</td></tr><tr><td rowspan="9" colspan="1">Comorbidities</td><td rowspan="1" colspan="1">Diabetes mellitus</td><td rowspan="1" colspan="1">9 (17.3%)</td><td rowspan="1" colspan="1">10 (18.2%)</td><td rowspan="1" colspan="1">19 (17.8%)</td></tr><tr><td rowspan="1" colspan="1">Missing</td><td rowspan="1" colspan="1">2 (3.8%)</td><td rowspan="1" colspan="1">2 (3.6%)</td><td rowspan="1" colspan="1">4 (3.7%)</td></tr><tr><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">19 (36.5%)</td><td rowspan="1" colspan="1">21 (38.2%)</td><td rowspan="1" colspan="1">40 (37.4%)</td></tr><tr><td rowspan="1" colspan="1">Ischemic heart disease</td><td rowspan="1" colspan="1">5 (9.6%)</td><td rowspan="1" colspan="1">2 (3.6%)</td><td rowspan="1" colspan="1">7 (6.5%)</td></tr><tr><td rowspan="1" colspan="1">Coronary artery disease</td><td rowspan="1" colspan="1">14 (26.9%)</td><td rowspan="1" colspan="1">17 (30.9%)</td><td rowspan="1" colspan="1">31 (29%)</td></tr><tr><td rowspan="1" colspan="1">Systolic or diastolic dysfunction of the left ventricle</td><td rowspan="1" colspan="1">1 (1.9%)</td><td rowspan="1" colspan="1">5 (9.1%)</td><td rowspan="1" colspan="1">6 (5.6%)</td></tr><tr><td rowspan="1" colspan="1">Pulmonary hypertension</td><td rowspan="1" colspan="1">3 (5.8%)</td><td rowspan="1" colspan="1">4 (7.3%)</td><td rowspan="1" colspan="1">7 (6.5%)</td></tr><tr><td rowspan="1" colspan="1">Depression or Anxiety disorder</td><td rowspan="1" colspan="1">4 (7.7%)</td><td rowspan="1" colspan="1">8 (14.5%)</td><td rowspan="1" colspan="1">12 (11.2%)</td></tr><tr><td rowspan="1" colspan="1">Substance Abuse (drugs; medication; alcohol)</td><td rowspan="1" colspan="1">6 (11.5%)</td><td rowspan="1" colspan="1">5 (9.1%)</td><td rowspan="1" colspan="1">11 (10.3%)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0002"><p><bold>Abbreviations</bold>: BMI, body mass index; IQR, interquartile range; n, number.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="s0003-s2002"><title>Implementation of Post-Acute Care Interventions</title><p>The implementation rates of almost all assessed post-acute care interventions were higher in the intervention group. Only the implementation rate of the intervention regarding post-discharge medical follow-up was higher in the control group. The highest implementation rate (98.2%) was for the physical activity intervention (in the intervention group); the two lowest were exacerbation and dyspnea management (both 1.9%) (in the control group). For interventions and their implementation rates in both groups, as well as the corresponding measure of association, see <xref rid="t0003" ref-type="table">Table 3</xref>. For all measured implementation rates of both groups, see <xref rid="f0001" ref-type="fig">Figure 1</xref>.
<table-wrap position="float" id="t0003"><label>Table 3</label><caption><p>Interventions and Their Implementation Rates</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1">Intervention</th><th colspan="3" rowspan="1">Interventions and Implementation rates n (%)</th><th rowspan="1" colspan="1">Measure of Association p-value; X<sup>2</sup>; Fisher&#x02019;s Exact Test</th></tr><tr><th rowspan="1" colspan="1">Control Group (n=52)</th><th rowspan="1" colspan="1">Intervention Group (n=55)</th><th rowspan="1" colspan="1">Total (n=107)</th><th rowspan="1" colspan="1">Link Between Group Allocation and Implementation Rate</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">1) Exacerbation Management</td><td rowspan="1" colspan="1">1 (1.9%)</td><td rowspan="1" colspan="1">53 (96.4%)</td><td rowspan="1" colspan="1">54 (50.5%)</td><td rowspan="1" colspan="1">p&#x0003c;0.001; X<sup>2</sup>(1)=95.367</td></tr><tr><td rowspan="1" colspan="1">2) Dyspnea Management</td><td rowspan="1" colspan="1">1 (1.9%)</td><td rowspan="1" colspan="1">29 (52.7%)</td><td rowspan="1" colspan="1">30 (28.0%)</td><td rowspan="1" colspan="1">p&#x0003c;0.001; X<sup>2</sup>(1)=34.193</td></tr><tr><td rowspan="1" colspan="1">3) Physical Activity</td><td rowspan="1" colspan="1">47 (90.4%)</td><td rowspan="1" colspan="1">54 (98.2%)</td><td rowspan="1" colspan="1">101 (94.4%)</td><td rowspan="1" colspan="1">Fisher&#x02019;s Exact Test (two-tailed) p=0.106</td></tr><tr><td rowspan="1" colspan="1">4) Rehabilitation</td><td rowspan="1" colspan="1">24 (46.2%)</td><td rowspan="1" colspan="1">44 (80%)</td><td rowspan="1" colspan="1">68 (63.6%)</td><td rowspan="1" colspan="1">p&#x0003c;0.001; X<sup>2</sup>(1)=13.219</td></tr><tr><td rowspan="1" colspan="1">5) Smoking Cessation (in current smokers)</td><td rowspan="1" colspan="1">5 (35.7%) (n=14)</td><td rowspan="1" colspan="1">14 (82.4%) (n=17)</td><td rowspan="1" colspan="1">19 (61.3%) (n=31)</td><td rowspan="1" colspan="1">p=0.008; X<sup>2</sup>(1)=7.039</td></tr><tr><td rowspan="1" colspan="1">6) Nutrition</td><td rowspan="1" colspan="1">10 (19.2%)</td><td rowspan="1" colspan="1">17 (30.9%)</td><td rowspan="1" colspan="1">27 (25.2%)</td><td rowspan="1" colspan="1">p=0.148; X<sup>2</sup>(1)=2.094</td></tr><tr><td rowspan="1" colspan="1">7) Inhalation Technique</td><td rowspan="1" colspan="1">16 (30.8%)</td><td rowspan="1" colspan="1">36 (65.5%)</td><td rowspan="1" colspan="1">52 (48.6%)</td><td rowspan="1" colspan="1">p&#x0003c;0.001; X<sup>2</sup>(1)=14.495</td></tr><tr><td rowspan="1" colspan="1">8) Influenza and Pneumococcal Vaccination</td><td rowspan="1" colspan="1">13 (25%)</td><td rowspan="1" colspan="1">37 (67.3%)</td><td rowspan="1" colspan="1">50 (46.7%)</td><td rowspan="1" colspan="1">p&#x0003c;0.001; X<sup>2</sup>(1)=19.188</td></tr><tr><td rowspan="1" colspan="1">9) Post-discharge Follow-up</td><td rowspan="1" colspan="1">50 (96.2%)</td><td rowspan="1" colspan="1">49 (89.1%)</td><td rowspan="1" colspan="1">99 (92.5%)</td><td rowspan="1" colspan="1">Fisher&#x02019;s Exact Test (two-tailed) p = 0.438</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><bold>Abbreviations</bold>: n, number; X<sup>2</sup>, Pearson&#x02019;s chi-square test.</p></fn></table-wrap-foot></table-wrap>
<fig position="float" id="f0001" fig-type="figure"><label>Figure 1</label><caption><p>Implementation rates of control and intervention group.</p></caption><graphic xlink:href="COPD-20-207-g0001" content-type="print-only" position="float"/><attrib><bold>Notes</bold>: *Smoking Cessation, subgroup of currently smoking patients (n = 14 (Control group); n = 17 (Intervention group)).</attrib></fig></p></sec></sec><sec id="s0004"><title>Discussion</title><p>In the current study, we compared defined post-acute care interventions before and after the implementation of a hospital-initiated integrated care program for patients with AECOPD. The implementation rates ranged from very low to very high, with significantly higher rates in the intervention group in six of the nine studied interventions (p &#x0003c; 0.05). Therefore, the assumption that the new integrated care program would lead to an increase in the implementation rate of post-acute care interventions in patients with AECOPD can be preliminarily confirmed.</p><p>Our results align with those of other studies,<xref rid="cit0012" ref-type="bibr">12</xref>,<xref rid="cit0034" ref-type="bibr">34&#x02013;36</xref> confirming both that post-acute care interventions are poorly implemented in the majority of institutions and that integrated care programs can improve implementation rates. However, the corroborating studies&#x02019; data sources, participants, interventions and settings are not directly comparable.</p><p>For example, in 2013, when Markun et al<xref rid="cit0012" ref-type="bibr">12</xref> performed a retrospective medical chart review in three hospitals in Zurich, Switzerland, they found that implementation rates for seven post-acute care interventions were generally low. With implementation rates of 1.9% each, <italic toggle="yes">patient education</italic> and <italic toggle="yes">self-management</italic> were the least frequently applied. As our control group data from 2020 show, some implementation rates had not improved in at least seven years. While Markun et al&#x02019;s<xref rid="cit0012" ref-type="bibr">12</xref> data were drawn from documentation generated by the attending physicians, we analyzed the available documentation for all involved health professionals. This may have contributed to our intervention group&#x02019;s significantly better results.</p><p>When Kaufmann et al<xref rid="cit0034" ref-type="bibr">34</xref> conducted a retrospective medical chart review in an outpatient setting in Switzerland, the patients examined had no exacerbation and, on average, significantly less advanced COPD than ours. One private practice (medical records n = 20) that had implemented the &#x0201c;living well with COPD&#x0201d; patient self-management program<xref rid="cit0037" ref-type="bibr">37</xref> showed significantly better documentation for nearly all measured interventions (p &#x0003c; 0.01) compared to the practices without this program. While such results attest to the value of that patient self-management program, differences between their patient sample and ours make it difficult to compare that practice&#x02019;s results with ours. The majority of our sample&#x02019;s patients had advanced COPD and were hospitalized. Further, their impaired physical condition may also have been related to a lower capacity and motivation to absorb and act on new knowledge regarding their COPD.</p><p>In an international European cluster randomized controlled trial,<xref rid="cit0036" ref-type="bibr">36</xref> where patients with AECOPD received the usual care in the control group and a new COPD care pathway in the intervention group, process indicators were compared. The authors concluded that performance on key evidence-based interventions was better after implementation of the new care pathway. However, the setting and the care pathway in their study are not directly comparable to ours (eg, not Nurse-led).</p><p>Our intervention group showed a very clear intervention effect, with implementation rates higher&#x02014;and in several cases, far higher&#x02014;for eight of the nine studied interventions. Nevertheless, there is room for improvement regarding implementation rates. Possible reasons why implementation is not fully realized in most interventions are as follows: 1. Some interventions, eg, those regarding nutrition in patients with Nutrition Risk Screening (NRS) &#x02265;4, are delivered post-discharge.<xref rid="cit0017" ref-type="bibr">17</xref> 2. In others, eg, to promote smoking cessation, the healthcare staff may be reluctant to address the topic.<xref rid="cit0017" ref-type="bibr">17</xref> 3. Continuity and regular training of healthcare professionals, eg, the nurses on the ward, cannot be guaranteed at all times.<xref rid="cit0014" ref-type="bibr">14</xref> 4. As hospital stays are often short, delayed prescriptions, eg, for physiotherapy, have been identified as barriers to intervention implementation.<xref rid="cit0014" ref-type="bibr">14</xref> 5. The ANP team has limited or no influence on post-discharge medical follow-up.</p><p>Overall, the intervention group&#x02019;s implementation rates show a successful implementation of the NICCO program. This level of success may have been facilitated by a number of exceptional factors, eg, the allocation of additional personnel resources, the presence of an ANP team, and the integration of the NICCO intervention into a broader care program. This program is based on a trustful relationship between the patients and the ANP team, whose members also address COPD-linked psychosocial aspects and burdensome emotions.<xref rid="cit0017" ref-type="bibr">17</xref></p><p>Based on this study&#x02019;s results, the following can be recommended to further develop the NICCO intervention: 1. Monitor the nutritional screening rate in order to start nutritional supplementation during hospitalization if indicated.<xref rid="cit0022" ref-type="bibr">22</xref> 2. Optimize evaluation and instruction of inhalation technique by having the ANP team take it over. 3. Include current vaccination recommendations for further development of the intervention, which now include vaccinations against SARS-CoV-2, zoster; diphtheria, tetanus, and pertussis (Tdap).<xref rid="cit0003" ref-type="bibr">3</xref></p></sec><sec id="s0005"><title>Limitations</title><p>This study&#x02019;s most notable limitations spring from our use of a retrospective medical chart review as a design. Operationalization was challenging, and inter-study comparison is limited.<xref rid="cit0023" ref-type="bibr">23</xref> Further, retrospective designs entail a risk of underreporting;<xref rid="cit0024" ref-type="bibr">24</xref> and our group assignments were not randomized. However, to ensure consistency of measurement, two qualified persons independently rated the studied interventions, after which the first author reviewed their ratings and made final decisions in cases of disagreement or ambiguity.</p></sec><sec id="s0006"><title>Conclusion</title><p>This study provides promising evidence that the introduction of a hospital-initiated integrated care program can significantly increase the implementation rate of selected post-acute care interventions in patients hospitalized due to COPD exacerbation.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank all participating patients living with COPD. We also thank Alice Hakim-Brunner, Regina Dunst and Kerstin Paulus for their valuable contributions during data collection. We owe many thanks to Annina Baltes-Wieser, Head of Nursing Division C, to Heidi Petry (PhD, RN), Head of the Centre of Clinical Nursing Science, to Silvia Ulrich (MD), Director of the Division of Pulmonology and to Gabi Brenner, Director of Nursing, for their support of this project. Further thanks go to Dr. Julia Braun of University Zurich&#x02019;s Epidemiology, Biostatistics and Prevention Institute for statistical support. We thank Chris Shultis for editing support. Finally, we are grateful to LUNGE ZUERICH Switzerland for their generous financial support.</p></ack><sec sec-type="data-availability" id="s0007"><title>Data Sharing Statement</title><p>In light of the sensitive nature of personal data, it is not available for unrestricted access. Any queries relating to data sharing should be directed to the corresponding author.</p></sec><sec sec-type="COI-statement" id="s0008"><title>Disclosure</title><p>Christian Clarenbach: received advisory fees from Roche, Novartis, Boehringer, GSK, Astra Zeneca, Sanofi, Vifor, OM Pharma, Grifols, Daiichi Sankyo, CSL Behring and MSD. Daniel Franzen: received advisory fees from Boehringer-Ingelheim, GSK, Astra Zeneca, IBSA, Schwabe Pharma, OM Pharma, and Pulmonx. The authors report no other conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="webpage"><collab>Federal Office of Public Health (FOPH)</collab>. <article-title>Chronic Respiratory Diseases (German)</article-title>. <source>Federal Office of Public Health (FOPH)</source>, <comment>Available from</comment>: <ext-link xlink:href="https://www.bag.admin.ch/bag/de/home/krankheiten/krankheiten-im-ueberblick/chronische-atemwegserkrankungen.html" ext-link-type="uri">https://www.bag.admin.ch/bag/de/home/krankheiten/krankheiten-im-ueberblick/chronische-atemwegserkrankungen.html</ext-link>. <date-in-citation>Accessed <month>April</month>
<day>28</day>, 2022</date-in-citation>.</mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Gutierrez Villegas</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Paz-Zulueta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Herrero-Montes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Paras-Bravo</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Madrazo Perez</surname>
<given-names>M</given-names></string-name>. <article-title>Cost analysis of chronic obstructive pulmonary disease (COPD): a systematic review</article-title>. <source><italic toggle="yes">Health Econ Rev</italic></source>. <year>2021</year>;<volume>11</volume>(<issue>1</issue>):<fpage>31</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13561-021-00329-9</pub-id><pub-id pub-id-type="pmid">34403023</pub-id>
</mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="webpage"><collab>Global Initiative for Chronic Obstructive Lung Disease</collab>. <article-title>Global strategy for the diagnosis, management, and prevention of COPD: 2023 report</article-title>. <year>2023</year>. <comment>Available from</comment>: <ext-link xlink:href="https://goldcopd.org/2023-gold-report-2/" ext-link-type="uri">https://goldcopd.org/2023-gold-report-2/</ext-link>. <date-in-citation>Accessed <month>January</month>
<day>01</day>, 2025</date-in-citation>.</mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Moy</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Teylan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Weston</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Gagnon</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Garshick</surname>
<given-names>E</given-names></string-name>. <article-title>Daily step count predicts acute exacerbations in a US cohort with COPD</article-title>. <source><italic toggle="yes">PLoS One</italic></source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<fpage>e60400</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0060400</pub-id><pub-id pub-id-type="pmid">23593211</pub-id>
</mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Poole</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>Chacko</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Wood-Baker</surname>
<given-names>RW</given-names></string-name>, <string-name><surname>Cates</surname>
<given-names>CJ</given-names></string-name>. <article-title>Influenza vaccine for patients with chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2006</year>;(<issue>1</issue>):<fpage>Cd002733</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD002733.pub2</pub-id><pub-id pub-id-type="pmid">16437444</pub-id>
</mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Howcroft</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Walters</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Wood-Baker</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Walters</surname>
<given-names>JA</given-names></string-name>. <article-title>Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2016</year>;<volume>12</volume>:<fpage>CD005074</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD005074.pub4</pub-id><pub-id pub-id-type="pmid">27990628</pub-id>
</mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Poot</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>Meijer</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kruis</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Smidt</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Chavannes</surname>
<given-names>NH</given-names></string-name>, <string-name><surname>Honkoop</surname>
<given-names>PJ</given-names></string-name>. <article-title>Integrated disease management interventions for patients with chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2021</year>;<volume>9</volume>:<fpage>CD009437</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD009437.pub3</pub-id><pub-id pub-id-type="pmid">34495549</pub-id>
</mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Zwerink</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Brusse-Keizer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van der Valk</surname>
<given-names>PD</given-names></string-name>, et al. <article-title>Self management for patients with chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2014</year>;<volume>2014</volume>(<issue>3</issue>):<fpage>Cd002990</fpage>. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD002990.pub3</pub-id><pub-id pub-id-type="pmid">24665053</pub-id>
</mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Long</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Howells</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Peters</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Blakemore</surname>
<given-names>A</given-names></string-name>. <article-title>Does health coaching improve health-related quality of life and reduce hospital admissions in people with chronic obstructive pulmonary disease? A systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Br J Health Psychol</italic></source>. <year>2019</year>;<volume>24</volume>(<issue>3</issue>):<fpage>515</fpage>&#x02013;<lpage>546</lpage>. doi:<pub-id pub-id-type="doi">10.1111/bjhp.12366</pub-id><pub-id pub-id-type="pmid">31033121</pub-id>
</mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Calle Rubio</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Lopez-Campos</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Soler-Cataluna</surname>
<given-names>JJ</given-names></string-name>, et al. <article-title>Variability in adherence to clinical practice guidelines and recommendations in COPD outpatients: a multi-level, cross-sectional analysis of the EPOCONSUL study</article-title>. <source><italic toggle="yes">Respir Res</italic></source>. <year>2017</year>;<volume>18</volume>(<issue>1</issue>):<fpage>200</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12931-017-0685-8</pub-id><pub-id pub-id-type="pmid">29197415</pub-id>
</mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Seys</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bruyneel</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Decramer</surname>
<given-names>M</given-names></string-name>, et al. <article-title>An international study of adherence to guidelines for patients hospitalised with a COPD exacerbation</article-title>. <source><italic toggle="yes">COPD</italic></source>. <year>2017</year>;<volume>14</volume>(<issue>2</issue>):<fpage>156</fpage>&#x02013;<lpage>163</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15412555.2016.1257599</pub-id><pub-id pub-id-type="pmid">27997254</pub-id>
</mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Markun</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Franzen</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Dalla Lana</surname>
<given-names>K</given-names></string-name>, et al. <article-title>Acute exacerbated COPD: room for improvement in key elements of care</article-title>. <source><italic toggle="yes">Int J Chron Obstruct Pulmon Dis</italic></source>. <year>2017</year>;<volume>12</volume>:<fpage>2969</fpage>&#x02013;<lpage>2975</lpage>. doi:<pub-id pub-id-type="doi">10.2147/copd.S145496</pub-id><pub-id pub-id-type="pmid">29066878</pub-id>
</mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Schmid-Mohler</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Clarenbach</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Brenner</surname>
<given-names>G</given-names></string-name>, et al. <article-title>Advanced nursing practice in COPD exacerbations: the solution for a gap in Switzerland?</article-title>
<source><italic toggle="yes">ERJ Open Res</italic></source>. <year>2020</year>;<volume>6</volume>(<issue>2</issue>):<fpage>00354</fpage>&#x02013;<lpage>2019</lpage>. doi:<pub-id pub-id-type="doi">10.1183/23120541.00354-2019</pub-id><pub-id pub-id-type="pmid">32577416</pub-id>
</mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>H&#x000fc;bsch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Clarenbach</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Chadwick</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Acceptability, appropriateness and feasibility of a nurse-led integrated care intervention for patients with severe exacerbation of COPD from the healthcare professional&#x02019;s perspective - A mixed method study</article-title>. <source><italic toggle="yes">Int J Chron Obstruct Pulmon Dis</italic></source>. <year>2023</year>;<volume>18</volume>:<fpage>1487</fpage>&#x02013;<lpage>1497</lpage>. doi:<pub-id pub-id-type="doi">10.2147/copd.S404712</pub-id><pub-id pub-id-type="pmid">37489242</pub-id>
</mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Buess</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Schilter</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Schneider</surname>
<given-names>T</given-names></string-name>, et al. <article-title>Treatment of COPD exacerbation in Switzerland: results and recommendations of the European COPD audit</article-title>. <source><italic toggle="yes">Respiration; International Review of Thoracic Diseases</italic></source>. <year>2017</year>;<volume>94</volume>(<issue>4</issue>):<fpage>355</fpage>&#x02013;<lpage>365</lpage>. doi:<pub-id pub-id-type="doi">10.1159/000477911</pub-id><pub-id pub-id-type="pmid">28719893</pub-id>
</mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Ryrs&#x000f8;</surname>
<given-names>CK</given-names></string-name>, <string-name><surname>Godtfredsen</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Kofod</surname>
<given-names>LM</given-names></string-name>, et al. <article-title>Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">BMC Pulm Med</italic></source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>154</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12890-018-0718-1</pub-id><pub-id pub-id-type="pmid">30219047</pub-id>
</mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Schmid-Mohler</surname>
<given-names>G</given-names></string-name>, <string-name><surname>H&#x000fc;bsch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Steurer-Stey</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Supporting behavior change after AECOPD - development of a hospital-initiated intervention using the behavior change wheel</article-title>. <source><italic toggle="yes">Int J Chron Obstruct Pulmon Dis</italic></source>. <year>2022</year>;<volume>17</volume>:<fpage>1651</fpage>&#x02013;<lpage>1669</lpage>. doi:<pub-id pub-id-type="doi">10.2147/COPD.S358426</pub-id><pub-id pub-id-type="pmid">35923357</pub-id>
</mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Schmid-Mohler</surname>
<given-names>G</given-names></string-name>, <string-name><surname>H&#x000fc;bsch</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Braun</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Effect of a nurse-led integrated care intervention on quality of life and rehospitalisation in Patients with severe exacerbation of COPD &#x02013; a pilot study</article-title>. <source><italic toggle="yes">Chron Respir Dis</italic></source>. <year>2024</year><volume>21</volume>: doi:<pub-id pub-id-type="doi">10.1177/14799731241291067</pub-id>.</mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="book"><collab>National Institute for Health and Care Excellence NICE</collab>. <source>National Institute for Health and Care Excellence: Guidelines. Chronic obstructive pulmonary disease in over 16s: diagnosis and management</source>. <publisher-loc>London</publisher-loc>: <publisher-name>National Institute for Health and Care Excellence (NICE)</publisher-name>; <year>2019</year>.</mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Lenferink</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Brusse-Keizer</surname>
<given-names>M</given-names></string-name>, <string-name><surname>van der Valk</surname>
<given-names>P DLPM</given-names></string-name>, <string-name><surname>Frith</surname>
<given-names>P A</given-names></string-name>, <string-name><surname>Zwerink</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Monninkhof</surname>
<given-names>E M</given-names></string-name>, <string-name><surname>van der Palen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Effing</surname>
<given-names>T W</given-names></string-name> and. (<year>2017</year>). <article-title>Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev.</italic></source>, <volume>2017</volume>(<issue>8</issue>), doi:<pub-id pub-id-type="doi">10.1002/14651858.CD011682.pub2</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Benzo</surname>
<given-names>R P</given-names></string-name>, <string-name><surname>Abascal-Bolado</surname>
<given-names>B</given-names></string-name> and <string-name><surname>Dulohery</surname>
<given-names>M M</given-names></string-name>. (<year>2016</year>). <article-title>Self-management and quality of life in chronic obstructive pulmonary disease (COPD): The mediating effects of positive affect</article-title>. <source><italic toggle="yes">Patient Educ Couns</italic></source>, <volume>99</volume>(<issue>4</issue>), <fpage>617</fpage>&#x02013;<lpage>623</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pec.2015.10.031</pub-id><pub-id pub-id-type="pmid">26632024</pub-id>
</mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Ferreira</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Brooks</surname>
<given-names>D</given-names></string-name>, <string-name><surname>White</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Goldstein</surname>
<given-names>R</given-names></string-name>. <article-title>Nutritional supplementation for stable chronic obstructive pulmonary disease</article-title>. <source><italic toggle="yes">Cochrane Database Syst Rev</italic></source>. <year>2012</year>;(<issue>12</issue>). doi:<pub-id pub-id-type="doi">10.1002/14651858.CD000998.pub3</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Vassar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Holzmann</surname>
<given-names>M</given-names></string-name>. <article-title>The retrospective chart review: important methodological considerations</article-title>. <source><italic toggle="yes">J Educ Eval Health Prof</italic></source>. <year>2013</year>;<volume>10</volume>:<fpage>12</fpage>. doi:<pub-id pub-id-type="doi">10.3352/jeehp.2013.10.12</pub-id><pub-id pub-id-type="pmid">24324853</pub-id>
</mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Hess</surname>
<given-names>DR</given-names></string-name>. <article-title>Retrospective studies and chart reviews</article-title>. <source><italic toggle="yes">Respir Care</italic></source>. <year>2004</year>;<volume>49</volume>(<issue>10</issue>):<fpage>1171</fpage>&#x02013;<lpage>1174</lpage>.<pub-id pub-id-type="pmid">15447798</pub-id>
</mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Gimeno-Santos</surname>
<given-names>E</given-names></string-name>
<italic toggle="yes">et al</italic>. (<year>2014</year>). <article-title>Determinants and outcomes of physical activity in patients with COPD: a systematic review</article-title>. <source><italic toggle="yes">Thorax</italic></source>, <volume>69</volume>(<issue>8</issue>), <fpage>731</fpage>&#x02013;<lpage>739</lpage>. doi:<pub-id pub-id-type="doi">10.1136/thoraxjnl-2013-204763</pub-id><pub-id pub-id-type="pmid">24558112</pub-id>
</mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Watz</surname>
<given-names>H</given-names></string-name>
<italic toggle="yes">et al</italic>. (<year>2014</year>). <article-title>An official European Respiratory Society statement on physical activity in COPD</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>, <volume>44</volume>(<issue>6</issue>), <fpage>1521</fpage>&#x02013;<lpage>1537</lpage>. doi:<pub-id pub-id-type="doi">10.1183/09031936.00046814</pub-id><pub-id pub-id-type="pmid">25359358</pub-id>
</mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Lindenauer</surname>
<given-names>P K</given-names></string-name>, <string-name><surname>Stefan</surname>
<given-names>M S</given-names></string-name>, <string-name><surname>Pekow</surname>
<given-names>P S</given-names></string-name>, <string-name><surname>Mazor</surname>
<given-names>K M</given-names></string-name>, <string-name><surname>Priya</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Spitzer</surname>
<given-names>K A</given-names></string-name>, <string-name><surname>Lagu</surname>
<given-names>T C</given-names></string-name>, <string-name><surname>Pack</surname>
<given-names>Q R</given-names></string-name>, <string-name><surname>Pinto-Plata</surname>
<given-names>V M</given-names></string-name> and <string-name><surname>ZuWallack</surname>
<given-names>R</given-names></string-name>. (<year>2020</year>). <article-title>Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries</article-title>. <source><italic toggle="yes">JAMA</italic></source>, <volume>323</volume>(<issue>18</issue>), <fpage>1813</fpage>&#x02013;<lpage>1823</lpage> doi:<pub-id pub-id-type="doi">10.1001/jama.2020.4437</pub-id><pub-id pub-id-type="pmid">32396181</pub-id>
</mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Bhattarai</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Walpola</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Mey</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Anoopkumar-Dukie</surname>
<given-names>S</given-names></string-name> and <string-name><surname>Khan</surname>
<given-names>S</given-names></string-name>. (<year>2020</year>). <article-title>Barriers and Strategies for Improving Medication Adherence Among People Living With COPD: A Systematic Review</article-title>. <source><italic toggle="yes">Respir Care</italic></source>, <volume>65</volume>(<issue>11</issue>), <fpage>1738</fpage>&#x02013;<lpage>1750</lpage>. doi:<pub-id pub-id-type="doi">10.4187/respcare.07355</pub-id><pub-id pub-id-type="pmid">32576706</pub-id>
</mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Souza</surname>
<given-names>M Luiza</given-names></string-name>, <string-name><surname>Meneghini</surname>
<given-names>A Cristina</given-names></string-name>, <string-name><surname>Ferraz</surname>
<given-names>&#x000c9;</given-names></string-name>, <string-name><surname>Vianna</surname>
<given-names>E Oliveira</given-names></string-name> and <string-name><surname>Borges</surname>
<given-names>M Carvalho</given-names></string-name>. (<year>2009</year>). <article-title>Knowledge of and technique for using inhalation devices among asthma patients and COPD patients</article-title>. <source><italic toggle="yes">J Bras Pneumol</italic></source>, <volume>35</volume>(<issue>9</issue>), <fpage>824</fpage>&#x02013;<lpage>831</lpage>. doi:<pub-id pub-id-type="doi">10.1590/S1806-37132009000900002</pub-id><pub-id pub-id-type="pmid">19820807</pub-id>
</mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Sanchis</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gich</surname>
<given-names>I</given-names></string-name> and <string-name><surname>Pedersen</surname>
<given-names>S</given-names></string-name>. (<year>2016</year>). <article-title>Systematic Review of Errors in Inhaler Use</article-title>. <source><italic toggle="yes">CHEST</italic></source>, <volume>150</volume>(<issue>2</issue>), <fpage>394</fpage>&#x02013;<lpage>406</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2016.03.041</pub-id><pub-id pub-id-type="pmid">27060726</pub-id>
</mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="newspaper"><collab>Global Initiative for Chronic Obstructive Lung Disease</collab>. <article-title>Global strategy for the diagnosis, management, and prevention of COPD: 2022 report</article-title>. <year>2021</year>.</mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><article-title>IBM SPSS statistics for windows, version 29.0</article-title>. <source><italic toggle="yes">IBM Corp</italic></source>. <year>2022</year>.</mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><collab>World Medical Association</collab>. <article-title>Declaration of Helsinki: ethical principles for medical research involving human subjects</article-title>. <source><italic toggle="yes">JAMA</italic></source>. <year>2013</year>;<volume>310</volume>(<issue>20</issue>):<fpage>2191</fpage>&#x02013;<lpage>2194</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2013.281053</pub-id><pub-id pub-id-type="pmid">24141714</pub-id>
</mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Kaufmann</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Markun</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hasler</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Performance measures in the management of chronic obstructive pulmonary disease in primary care: a retrospective analysis</article-title>. <source><italic toggle="yes">Praxis</italic></source>. <year>2015</year>;<volume>104</volume>(<issue>17</issue>):<fpage>897</fpage>&#x02013;<lpage>907</lpage>. doi:<pub-id pub-id-type="doi">10.1024/1661-8157/a002101</pub-id><pub-id pub-id-type="pmid">26286494</pub-id>
</mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Steurer-Stey</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dallalana</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Jungi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rosemann</surname>
<given-names>T</given-names></string-name>. <article-title>Management of chronic obstructive pulmonary disease in Swiss primary care: room for improvement</article-title>. <source><italic toggle="yes">Qual Primary Care</italic></source>. <year>2012</year>;<volume>20</volume>(<issue>5</issue>):<fpage>365</fpage>&#x02013;<lpage>373</lpage>.<pub-id pub-id-type="pmid">23114004</pub-id>
</mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Vanhaecht</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Lodewijckx</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Sermeus</surname>
<given-names>W</given-names></string-name>, et al. <article-title>Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: a cluster randomized trial</article-title>. <source><italic toggle="yes">Int J Chron Obstruct Pulmon Dis</italic></source>. <year>2016</year>;<volume>11</volume>:<fpage>2897</fpage>&#x02013;<lpage>2908</lpage>. doi:<pub-id pub-id-type="doi">10.2147/COPD.S119849</pub-id><pub-id pub-id-type="pmid">27920516</pub-id>
</mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="webpage"><collab>Living well with COPD. Living well with COPD</collab>. <comment>Available from</comment>: <ext-link xlink:href="http://www.livingwellwithcopd.com" ext-link-type="uri">www.livingwellwithcopd.com</ext-link>. <date-in-citation>Accessed <day>15th</day>, <month>March</month>, 2022</date-in-citation>.</mixed-citation></ref></ref-list></back></article>